Barrett AM, Britton ZT, Carrasco RA, Breen S, et al. Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancer. Clin Cancer Res 2024 Sep 25. doi: 10.1158/1078-0432.CCR-24-1853.
PMID: 39321207